Development of Immunopathogenesis Strategies to Treat Behçet’s Disease

Abstract EN

Behçet disease is a chronic relapsing vasculitis with unclear etiology and immunopathogenesis.

Antigenic stimuli, antigen presenting cells, T cells, monocyte, and neutrophil and endothelial cells are major parts of the pathology of the disease.

Understanding of the new pathogenic mechanisms based on molecular structure of the disease helps us in improving the novel therapeutic modalities.

These drugs target specific and nonspecific inhibition of the immun system.

These therapies include biologic agents, new topical and systemic immunosuppressants, tolerizing agents, and immunoablation.

Novel treatment will be promising to treat the especially recalcitrant cases to conventional therapy.

In this paper, new aspect of the immunopathogenesis of Behçet’s diseases and novel treatment modalities will be discussed.